Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-26a-2-3p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 120, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
CLDN12 hsa-miR-26a-2-3p low: 0 high: 3 2 3 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:90413895-90413920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:90413895-90413920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr7:90413895-90413920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PKN2 hsa-miR-26a-2-3p low: 0 high: 3 2 2 2 0.606
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:88834915-88834938 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:88834915-88834938 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:88813574-88813595 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PIK3C3 hsa-miR-26a-2-3p low: 0 high: 2 1 2 1 0.652
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr18:42013515-42013536 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr18:42013515-42013536 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CCND1 hsa-miR-26a-2-3p low: 0 high: 2 2 2 2 0.661
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:69653839-69653857 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:69651624-69651639 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MTF2 hsa-miR-26a-2-3p low: 0 high: 2 2 2 2 0.469
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:93137715-93137725 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:93136914-93136932 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MALSU1 hsa-miR-26a-2-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:23309475-23309496 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:23309475-23309496 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SERTAD3 hsa-miR-26a-2-3p low: 0 high: 2 1 2 1 0.504
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:40440962-40440984 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr19:40440962-40440984 HITS-CLIP POSITIVE DIRECT TarBase 7.0
YIPF6 hsa-miR-26a-2-3p low: 0 high: 2 1 2 1 0.613
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chrX:68533367-68533393 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chrX:68533367-68533393 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SRP14 hsa-miR-26a-2-3p low: 0 high: 2 1 1 1 0.731
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr15:40036219-40036245 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr15:40036200-40036227 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZKSCAN2 hsa-miR-26a-2-3p low: 0 high: 1 2 2 1 0.491
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:25237986-25238009 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
CDC27 hsa-miR-26a-2-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:47123890-47123917 PAR-CLIP POSITIVE DIRECT TarBase 7.0
BRCA1 hsa-miR-26a-2-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr17:43093701-43093722 HITS-CLIP POSITIVE DIRECT TarBase 7.0
AGPS hsa-miR-26a-2-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr2:177541226-177541251 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZRANB1 hsa-miR-26a-2-3p low: 0 high: 1 1 1 1 0.494
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr10:124985283-124985304 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CYBRD1 hsa-miR-26a-2-3p low: 0 high: 1 1 1 1 0.607
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:171557000-171557011 PAR-CLIP POSITIVE DIRECT TarBase 7.0
ZC3H7B hsa-miR-26a-2-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:41359612-41359621 HITS-CLIP POSITIVE DIRECT TarBase 7.0
USP11 hsa-miR-26a-2-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chrX:47248087-47248105 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CDK6 hsa-miR-26a-2-3p low: 0 high: 1 1 1 1 0.786
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:92614256-92614281 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUFIP2 hsa-miR-26a-2-3p low: 0 high: 1 1 1 1 0.568
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:29258523-29258547 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLAIN2 hsa-miR-26a-2-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr4:48382796-48382819 HITS-CLIP POSITIVE DIRECT TarBase 7.0